The syntax of comparison constructions in diachronic and dialectal perspective by Agnes Jäger

Get full text

The comparative cycle in crosslinguistic perspective by Agnes Jäger

Get full text

Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administr... by Margreet Franken, Tim Kanters, Jules Coenen, Paul de Jong, Agnes Jager, Carin Uyl-de Groot

Get full text

Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer by Noortje Verschoor, Marcel Smid, Agnes Jager, Stefan Sleijfer, Saskia M. Wilting, John W. M. Martens

Get full text

Tamoxifen use and potential effects on liver parenchyma: A long‐term prospective transient elastographic evaluation by C. Louwrens Braal, Robert J. deKnegt, Agnes Jager, Stijn L. W. Koolen, Ron H. J. Mathijssen, Karel Eechoute

Get full text

The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer by Mark van Barele, Bernadette A.M. Heemskerk-Gerritsen, Helena C. van Doorn, Marjanka K. Schmidt, Maartje J. Hooning, Agnes Jager

Get full text

Corrigendum to “The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer” [Breast 52 (2020)... by Mark van Barele, Bernadette A.M. Heemskerk-Gerritsen, Helena C. van Doorn, Marjanka K. Schmidt, Maartje J. Hooning, Agnes Jager

Get full text

Development and validation of a functional ex vivo paclitaxel and eribulin sensitivity assay for breast cancer, the REMIT assay by Zofia M. Komar, Nicole S. Verkaik, Ahmed Dahmani, Elodie Montaudon, Roland Kanaar, Adriaan B. Houtsmuller, Agnes Jager, Elisabetta Marangoni, Dik C. van Gent

Get full text

Patient-derived breast model repository, a tool for hyperthermia treatment planning and applicator design by Ioannis Androulakis, Kemal Sumser, Melanie N. D. Machielse, Linetta Koppert, Agnes Jager, Remi Nout, Martine Franckena, Gerard C. van Rhoon, Sergio Curto

Get full text

High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation by Joost G. E. Verbeek, Vincent M. T. de Jong, Hanna M. Wijnja, Agnes Jager, Sabine C. Linn, Valesca P. Retèl, Wim H. van Harten

Get full text

Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice by Nathalie I. Bouwer, Agnes Jager, Crista Liesting, Marcel J.M. Kofflard, Jasper J. Brugts, Jos J.E.M. Kitzen, Eric Boersma, Mark-David Levin

Get full text

High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providers by Joost G.E. Verbeek, Leyla Azarang, Luis E. Pilli, Vincent M.T. de Jong, Agnes Jager, Sabine C. Linn, Valesca P. Retèl, Wim H. van Harten

Get full text

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane by Dinja T. Kruger, Maurice P.H.M. Jansen, Inge R.H.M. Konings, Wouter M. Dercksen, Agnes Jager, Jamal Oulad Hadj, Stefan Sleijfer, John W.M. Martens, Epie Boven

Get full text

Corrigendum to ‘Adverse health effects after breast cancer up to 14 years after diagnosis’ [The Breast 61 (2022) 22–28] by Marianne J. Heins, Kelly M. de Ligt, Janneke Verloop, Sabine Siesling, Joke C. Korevaar, Annette Berendsen, Daan Brandenbarg, Anneriet Dassen, Agnes Jager, Jacqueline Hugtenburg, Gerda van der Weele

Get full text

Adverse health effects after breast cancer up to 14 years after diagnosis by Marianne J. Heins, Kelly M. de Ligt, Janneke Verloop, Sabine Siesling, Joke C. Korevaar, Annette Berendsen, Daan Brandenbarg, Anneriet Dassen, Agnes Jager, Jacqueline Hugtenburg, Gerda van der Weele

Get full text

Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients by Marjolijn M. Ladan, Titia G. Meijer, Nicole S. Verkaik, Cecile de Monye, Linetta B. Koppert, Esther Oomen-de Hoop, Carolien H. M. van Deurzen, Roland Kanaar, Julie Nonnekens, Dik C. van Gent, Agnes Jager

Get full text

Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort by Delal Akdeniz, Iris Kramer, Carolien H. M. vanDeurzen, Bernadette A. M. Heemskerk‐Gerritsen, Michael Schaapveld, Pieter J. Westenend, Adri C. Voogd, Agnes Jager, Ewout W. Steyerberg, Stefan Sleijfer, Marjanka K. Schmidt, Maartje J. Hooning

Get full text

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions... by Agnes Jager, Elisabeth G. E. de Vries, C. Willemien Menke-van der Houven van Oordt, Patrick Neven, Clasina M. Venema, Andor W. J. M. Glaudemans, Yamei Wang, Rebecca G. Bagley, Maureen G. Conlan, Philippe Aftimos

Get full text

HER2-low breast cancer shows a lower immune response compared to HER2-negative cases by Nadine S. van den Ende, Marcel Smid, Annemieke Timmermans, Johannes B. van Brakel, Tim Hansum, Renée Foekens, Anita M. A. C. Trapman, Bernadette A. M. Heemskerk-Gerritsen, Agnes Jager, John W. M. Martens, Carolien H. M. van Deurzen

Get full text

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor by Nick Beije, Wendy Onstenk, Jaco Kraan, Anieta M. Sieuwerts, Paul Hamberg, Luc Y. Dirix, Anja Brouwer, Felix E. de Jongh, Agnes Jager, Caroline M. Seynaeve, Ngoc M. Van, John A. Foekens, John W.M. Martens, Stefan Sleijfer

Get full text